This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, T.-K. Articles by Liu, L. F. Search for Related Content PubMed PubMed Citation Articles by Li, T.-K. Articles by Liu, L. F.

Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug

¹ Department of Pharmacology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey;
² Department of Molecular Pharmacology, St. Jude Children’s Research Hospital, Memphis, Tennessee; and
³ Department of Pharmaceutical Chemistry, Rutgers, The State University of New Jersey, Piscataway, New Jersey

8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6] naphthyridin-6-one (ARC-111, topovale) is a new synthetic antitumor agent. In the current study, we show that ARC-111 is highly potent in scid mice carrying human tumor xenografts. ARC-111 was shown to be as active as camptothecin (CPT)-11 in the HCT-8 colon tumor model, and compared favorably with CPT-11 and topotecan in the SKNEP anaplastic Wilms’ tumor model. In tissue culture models, ARC-111 exhibited low nM cytotoxicity against a panel of cancer cells. ARC-111 cytotoxicity as well as ARC-111-induced apoptosis was reduced >100-fold in CPT-resistant topoisomerase I (TOP1)-deficient P388/CPT45 cells as compared with P388 cells. Similarly, ARC-111 cytotoxicity was greatly reduced in CPT-resistant CPT-K5 and U937/CR cells, which express CPT-resistant mutant TOP1, suggesting that the cytotoxic target of ARC-111 is TOP1. Indeed, ARC-111, like CPT, was shown to induce reversible TOP1 cleavage complexes in tumor cells as evidenced by specific reduction of the TOP1 immunoreactive band in a band depletion assay, as well as elevation of small ubiquitin modifier-TOP1 conjugate levels and activation of 26S proteasome-mediated degradation of TOP1. Unlike CPT, ARC-111 is not a substrate for the ATP-binding cassette transporter breast cancer resistance protein. In addition, ARC-111 cytotoxicity was not significantly reduced in the presence of human serum albumin. These results suggest that ARC-111 is a promising new TOP1-targeting antitumor drug with a different drug resistance profile than CPT.

This article has been cited by other articles:

				L. S. Kurtzberg, T. Battle, C. Rouleau, R. G. Bagley, N. Agata, M. Yao, S. Schmid, S. Roth, J. Crawford, R. Krumbholz, et al. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors Mol. Cancer Ther., October 1, 2008; 7(10): 3212 - 3222. [Abstract] [Full Text] [PDF]

				S. Liu, R. B. Klisovic, T. Vukosavljevic, J. Yu, P. Paschka, L. Huynh, J. Pang, P. Neviani, Z. Liu, W. Blum, et al. Targeting AML1/ETO-Histone Deacetylase Repressor Complex: A Novel Mechanism for Valproic Acid-Mediated Gene Expression and Cellular Differentiation in AML1/ETO-Positive Acute Myeloid Leukemia Cells J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 953 - 960. [Abstract] [Full Text] [PDF]

				C. Losasso, E. Cretaio, K. Palle, L. Pattarello, M.-A. Bjornsti, and P. Benedetti Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell Lethality J. Biol. Chem., March 30, 2007; 282(13): 9855 - 9864. [Abstract] [Full Text] [PDF]

				M. Huang, H. Gao, Y. Chen, H. Zhu, Y. Cai, X. Zhang, Z. Miao, H. Jiang, J. Zhang, H. Shen, et al. Chimmitecan, a Novel 9-Substituted Camptothecin, with Improved Anticancer Pharmacologic Profiles In vitro and In vivo Clin. Cancer Res., February 15, 2007; 13(4): 1298 - 1307. [Abstract] [Full Text] [PDF]

				H. R. Jacquiau, R. C. A. M. van Waardenburg, R. J. D. Reid, M. H. Woo, H. Guo, E. S. Johnson, and M.-A. Bjornsti Defects in SUMO (Small Ubiquitin-related Modifier) Conjugation and Deconjugation Alter Cell Sensitivity to DNA Topoisomerase I-induced DNA Damage J. Biol. Chem., June 24, 2005; 280(25): 23566 - 23575. [Abstract] [Full Text] [PDF]

				M.-A. Bjornsti Cellular Responses to Replication Stress: Lessons from Yeast Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 250 - 253. [Full Text] [PDF]

				P. Daroui, S. D. Desai, T.-K. Li, A. A. Liu, and L. F. Liu Hydrogen Peroxide Induces Topoisomerase I-mediated DNA Damage and Cell Death J. Biol. Chem., April 9, 2004; 279(15): 14587 - 14594. [Abstract] [Full Text] [PDF]